Three-day ODAC to review data from confirmatory trials of PD-1/PD-L1 drugs marketed under accelerated approval March 12, 2021Vol.47 No.10By Paul Goldberg
Conversation with The Cancer Letter Working in concert with NCI’s $500M data federation in childhood cancer, St. Jude demonstrates utility of its genomic database March 12, 2021Vol.47 No.10By Matthew Bin Han Ong
In Brief Xiongbin Lu named co-program leader of EDT research program at IU Simon March 12, 2021Vol.47 No.10
In Brief Regina Bou Puerto, Mijin Kim named 2021 Kravis Women in Science Endeavor fellowship grant recipients March 12, 2021Vol.47 No.10
Clinical Roundup NCCN provides COVID-19 treatment advice; updates vaccine guidance for cancer patients March 12, 2021Vol.47 No.10
Clinical Roundup UNC Lineberger review demonstrates benefits and harms from LDCT screening March 12, 2021Vol.47 No.10
Clinical Roundup National cancer genetic screening program at Emory offers at-home testing March 12, 2021Vol.47 No.10
Clinical Roundup Multisystem failure regarding frailty necessitates multisystem intervention March 12, 2021Vol.47 No.10
Drugs & Targets FDA approves Fotivda for relapsed or refractory advanced renal cell carcinoma March 12, 2021Vol.47 No.10
